Efficacy of sodium glucose cotransporter 2 inhibitors on hepatic fibrosis and steatosis in non-alcoholic fatty liver disease: an updated systematic review and meta-analysis.

The meta-analysis showed a trend towards a reduction in the liver proton density fat fraction at the end of treatment (MD: − 2.61%, 95% CI [− 5.05, − 0.17], p = 0.04, I 2 = 78%, low certainty of evidence).

also in 33,237 other papers